Retraction Note: MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17

W.-Z. Su, L.-F. Ren

Department of Respiration, Shanxi Cancer Hospital, Taiyuan, China

---

• Oncology

The article “MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17” by W.-Z. Su, L.-F. Ren published in Eur Rev Med Pharmacol Sci 2019; 23 (8): 3390-3400–DOI: 10.26355/eurrev_201904_17703–PMID: 31081094 has been retracted in accordance with the Publisher and the Editor in Chief.

Following some concerns raised on PubPeer (https://pubpeer.com/publications/2E8256B0FA92987A3510C854E633DA), the Journal has started an investigation to assess the validity of the results as well as possible figure manipulation.

The journal’s investigation identified multiple instances of figure duplication, specifically in panel E of Figure 2 and in the Western blots of Figure 4, which appear to overlap with images from previously published articles. In addition, a duplication was detected within panel C of Figure 5.

The authors were contacted and informed of the ongoing investigation, and were requested to provide the original data supporting the manuscript. The authors responded that, due to their relocation and lack of access to the original computer files, the underlying data could not be retrieved.

As a result, the Journal has decided to retract this article.

This article has been retracted. The Publisher apologizes for any inconvenience this may cause.

MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17

Free PDF Download